AI in Drug Discovery

The potential of artificial intelligence (AI) is reshaping drug discovery by enabling exploration of a broader chemical space. DeepCure is focused on using AI to discover small molecule therapies for autoimmune diseases, addressing challenges that traditional methods have struggled with. By leveraging advanced physics simulations alongside AI, DeepCure identifies numerous binding opportunities for potential drug molecules, reducing design biases typically present in traditional approaches. This innovative methodology not only enhances the efficiency of the discovery process but also improves the likelihood of developing effective, safe small molecule drugs.